Bajoo Laboratories New opened Bioanalysis Center In its own pharmaceutical factory Silver. It has been approved by I grow These tests are designed to develop new products and carry out the bioanalytical phase of bioequivalence studies, and are essential for determining whether a pharmaceutical product is bioequivalent to a reference product and thus ensuring its safety, efficacy and quality, allowing to speed up processes, reduce times and increase the accuracy of results.
This new center represents another step for the company in its commitment to innovation and integrating cutting-edge technology to enhance the quality of its products and rigorous scientific development.
“Science and technology are advancing at an unprecedented speed, and as a company, we have a responsibility to accompany this development with concrete decisions.”He mentioned Edgardo Vasquez, General Manager of Bajoo Laboratories. He added: “This new move reflects our conviction that investing in innovation not only strengthens our operations, but also allows us to improve access to safe, effective, high-quality treatments, with a real impact on people’s quality of life.”.
Authoritarians don’t like this
The practice of professional and critical journalism is an essential pillar of democracy. This is why it bothers those who believe they are the bearers of the truth.
The Bioanalysis Center provides an improved work environment, with more interconnected areas that encourage collaboration between teams and streamline processes. Its opening comes as part of an innovation strategy that includes all areas of the company.
This new space joins a select group of bioanalysis centers enabled by ANMAT, which today ranks fifth in the country, and which positions Bajo as a key player in strengthening local capabilities in clinical research and drug development.
With a focus on accessibility, delivering maximum quality and effectiveness to improve community health, Laboratorios Bagó currently operates in more than 100 research and development projects With a high level of innovation and application of artificial intelligence. Among the technologies used, pharmacometric tools and in vitro and in silico methodologies stand out, which allow improving the development and control of products with high standards of quality, accuracy and efficiency.
With more than 90 years of experience, the company has fostered an innovative model that combines scientific excellence, technological development and strategic alliances with scientific and academic organizations. As a result, it obtained 148 patents, 56 for discoveries of original molecules, and 92 for manufacturing procedures.
Founded in 1934, Laboratorios Bagó is an Argentine pharmaceutical company with a strong presence in Latin America and globally. Its products reach 50 countries. Its mission is to provide distinguished products and services that contribute to improving community health in an ethical and sustainable manner.